Neal Bradsher · Broadwood Capital
Broadwood Partners' letter to STAAR Surgical shareholders, against the sale to Alcon
Published 8 Oct 2025Available at SEC.gov, link checked 20 Nov 2026Activist letter · Investment
The view as filed on 8 Oct 2025, not a statement of what the author thinks today.
What to notice
- 1
Broadwood notes that on 23 July 2025 management projected 2027 EBITDA at twice the company's best year, then cut that forecast by 20% ten days later, after Alcon agreed to pay $28.
Continue the investment thesis
See the 3 remaining takeaways on what this investor is arguing and why, and every analysis across the Letters & Theses library.
Checking what you can open…
“We must now protect ourselves.”
Why read it
A short, forensic case against a takeover built from the target's own proxy: projections that changed within days, management's deal payouts and a discount rate that set the fairness range.
About this letter
Neal C. Bradsher, founder and president of Broadwood Capital, the general partner of Broadwood Partners, signed this letter to the shareholders of STAAR Surgical on 8 October 2025. Broadwood, which owned 27.5% of the company's shares and describes itself as one of its most committed investors for more than 30 years, filed it with the SEC the same day on form DFAN14A, inside a press release, ahead of a special meeting on 23 October.
The letter argues against the proposed sale of STAAR to Alcon at $28 per share, agreed in August 2025. It makes its case mainly from the company's own merger proxy: the management projections presented before and after the deal was struck, the compensation executives would receive on closing, and the cost-of-capital assumption behind the financial adviser's fairness opinion. It then turns to the board, before urging shareholders to vote against the deal. The filing also carries a later press release on a proxy adviser's recommendation.
Companies
Themes
- governance
- valuation
- management change
- board change
L3VLUP does not host this document. It belongs to Broadwood Capital and is a public SEC filing; the notes above are L3VLUP’s reading of it.
The same argument, elsewhere
- Mantle Ridge's open letter to Air Products shareholders, a week before the vote · Mantle Ridge
- JANA Partners' second letter to Lamb Weston's board, on what shareholders told it · Scott Ostfeld, JANA Partners
- JANA Partners' letter to the Lamb Weston board on its record and a possible sale · Scott Ostfeld, JANA Partners
- Trian's March 2024 letter to Disney shareholders · Trian Fund Management